London, UK, 15 January 2007: BioProgress plc ('BioProgress' or the 'Company') (AIM: BPRG; NASDAQ: BPRG), the speciality pharma and healthcare company, today announces the launch of a further two new products within its US portfolio through its subsidiary Dexo LLC.
